A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Federal University of Minas Gerais
SpeciCare
Petra Pharma
Institut National de la Santé Et de la Recherche Médicale, France
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Center, Korea